CompletedNot Applicable

Identification of New Inborn Errors of Immunity

Switzerland9 participantsStarted 2016-09-23

Plain-language summary

Analysis of DNA samples of patients with molecularly undetermined PID by whole exome/genome sequencing. Transcriptome analysis of patients with molecularly undetermined PID.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with primary immunodeficiency (PID) * Male and Female participants 0 years to adult age (any) * Written informed consent by the participant after information about the research project Exclusion Criteria: * Secondary immunodeficiency * Refusal to enter the study

What they're measuring

Identification of the genetic defects

Timeframe: 10 years

Trial details

NCT IDNCT03414528

SponsorUniversity of Zurich

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Primary Immune Deficiency Disorder trials